Protection against reinfection with SARS-CoV-2 omicron BA.2.75 * sublineage
Protection against reinfection with SARS-CoV-2 omicron BA.2.75 * sublineage
Abstract
Latif Ali N.、Nasrallah Gheyath K.、Al-Kanaani Zaina、Jeremijenko Andrew、Shaik Riyazuddin M.、Abdul-Rahim Hanan F.、Al-Thani Mohamed H.、Abu-Raddad Laith J.、Chemaitelly Hiam、Al-Khatib Hebah A.、Ayoub Houssein H.、Al-Khal Abdullatif、Smatti Maria K.、Al-Kuwari Einas、Altarawneh Heba N.、Tang Patrick、Bertollini Roberto、Yassine Hadi M.、Butt Adeel A.、Kaleeckal Anvar H.、Coyle Peter、Al-Kuwari Mohamed G.、Hasan Mohammad R.、Al-Romaihi Hamad E.
Hamad Medical CorporationQatar UniversityHamad Medical CorporationHamad Medical CorporationHamad Medical CorporationQatar UniversityMinistry of Public HealthWeill Cornell Medicine-Qatar, Cornell UniversityWeill Cornell Medicine-Qatar, Cornell UniversityQatar UniversityQatar UniversityHamad Medical CorporationQatar UniversityHamad Medical CorporationWeill Cornell Medicine-Qatar, Cornell UniversitySidra MedicineMinistry of Public HealthQatar UniversityHamad Medical CorporationHamad Medical CorporationHamad Medical CorporationPrimary Health Care CorporationSidra MedicineMinistry of Public Health
预防医学
Latif Ali N.,Nasrallah Gheyath K.,Al-Kanaani Zaina,Jeremijenko Andrew,Shaik Riyazuddin M.,Abdul-Rahim Hanan F.,Al-Thani Mohamed H.,Abu-Raddad Laith J.,Chemaitelly Hiam,Al-Khatib Hebah A.,Ayoub Houssein H.,Al-Khal Abdullatif,Smatti Maria K.,Al-Kuwari Einas,Altarawneh Heba N.,Tang Patrick,Bertollini Roberto,Yassine Hadi M.,Butt Adeel A.,Kaleeckal Anvar H.,Coyle Peter,Al-Kuwari Mohamed G.,Hasan Mohammad R.,Al-Romaihi Hamad E..Protection against reinfection with SARS-CoV-2 omicron BA.2.75 * sublineage[EB/OL].(2025-03-28)[2025-07-23].https://www.medrxiv.org/content/10.1101/2022.10.29.22281606.点此复制
评论